What is neutropenia and when should I go to the ER during chemo

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Understanding Neutropenia During Chemotherapy

What is Neutropenia?

Neutropenia is a condition where you have a lower-than-normal number of neutrophils — a type of white blood cell that fights bacterial infections. Think of neutrophils as your body's frontline defense against germs.

Normal neutrophil count: 2,500-7,500 cells per microliter of blood

Neutropenia levels:

  • Mild: 1,000-1,500 cells/microliter
  • Moderate: 500-1,000 cells/microliter
  • Severe: Below 500 cells/microliter (highest infection risk)

Why Does Chemo Cause Neutropenia?

Chemotherapy drugs kill rapidly dividing cells — including cancer cells AND healthy bone marrow cells that produce white blood cells. This temporary drop in neutrophils typically occurs 7-14 days after chemo and usually recovers within 3-4 weeks.


When to Go to the ER: Red Flag Symptoms

Go to the emergency room immediately if you have:

🔴 Fever of 100.4°F (38°C) or higher — This is the most important warning sign. Even a low fever with neutropenia can indicate a serious infection.

🔴 Chills or sweating — Often accompanies infection

🔴 Severe fatigue or weakness — Beyond normal chemo tiredness

🔴 Difficulty breathing or chest pain — Possible pneumonia or other serious condition

🔴 Severe abdominal pain or persistent diarrhea — Could indicate infection in your digestive system

🔴 Confusion or difficulty concentrating — May indicate serious infection

🔴 Severe mouth sores with difficulty swallowing — Risk for serious oral infections

🔴 Unexplained bleeding or bruising — May indicate other blood cell problems


Prevention Strategies to Discuss With Your Team

According to ASCO (American Society of Clinical Oncology) Guidelines, preventive measures include:

  • G-CSF (growth factor) injections — Medications like filgrastim that stimulate white blood cell production
  • Prophylactic antibiotics — Sometimes prescribed during high-risk periods
  • Careful hygiene — Hand washing, avoiding crowds, staying away from sick people
  • Dietary precautions — Avoiding raw foods that may carry bacteria
  • Regular blood count monitoring — Your doctor will check your neutrophil levels frequently

Questions to Ask Your Oncology Team

  1. What is my expected neutropenia timeline after each chemo dose?
  2. Will I receive G-CSF or other preventive medications?
  3. What exact temperature or symptoms should trigger an ER visit?
  4. Do you have an on-call number for urgent questions outside office hours?
  5. Should I have blood work done before my next chemo if I had symptoms?

Key Takeaway

Don't wait or minimize fever during chemo. Neutropenia-related infections can progress rapidly. Your oncology team would rather evaluate you and find nothing wrong than have you delay care. Many cancer centers have urgent care lines specifically for chemo patients — ask if yours does.

According to the National Cancer Institute (NCI), prompt evaluation of fever in neutropenic patients is critical because infections can become life-threatening within hours.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...

TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2